Jpmorgan Chase & CO Cerus Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CERS
# of Institutions
148Shares Held
146MCall Options Held
191KPut Options Held
43.9K-
Baker Bros. Advisors LP New York, NY19.5MShares$30.4 Million0.46% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$28.4 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$21.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$16.4 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.58MShares$13.4 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $276M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...